{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:05:55Z","timestamp":1791479155757,"version":"4.3.4"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:00:00Z","timestamp":1456704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1038\/ng.3520","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T11:12:06Z","timestamp":1456744326000},"page":"407-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":874,"title":["Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations"],"prefix":"10.1038","volume":"48","author":[{"given":"Raphael","family":"Bueno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric W","family":"Stawiski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard D","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Durinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"De Rienzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zora","family":"Modrusan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Gnad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thong T","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijay S","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian R","family":"Chirieac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Sciaranghella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhien","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne E","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiara J","family":"Munir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A","family":"Hackney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitabha","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Guillory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Toy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Jiun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Stinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhra","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Sugarbaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic J","family":"de Sauvage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somasekar","family":"Seshagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,29]]},"reference":[{"key":"BFng3520_CR1","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.hoc.2005.09.011","volume":"19","author":"R Bueno","year":"2005","unstructured":"Bueno, R. Multimodality treatments in the management of malignant pleural mesothelioma: an update. Hematol. Oncol. Clin. North Am. 19, 1089\u20131097, vii (2005).","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"BFng3520_CR2","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.mpmed.2008.02.001","volume":"36","author":"R Rudd","year":"2008","unstructured":"Rudd, R. Asbestos and the lung. Medicine 36, 261\u2013264 (2008).","journal-title":"Medicine"},{"key":"BFng3520_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/jcp.22724","volume":"227","author":"M Carbone","year":"2012","unstructured":"Carbone, M. et al. Malignant mesothelioma: facts, myths, and hypotheses. J. Cell. Physiol. 227, 44\u201358 (2012).","journal-title":"J. Cell. Physiol."},{"key":"BFng3520_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.aogh.2014.09.016","volume":"80","author":"AL Frank","year":"2014","unstructured":"Frank, A.L. & Joshi, T.K. The global spread of asbestos. Ann. Glob. Health 80, 257\u2013262 (2014).","journal-title":"Ann. Glob. Health"},{"key":"BFng3520_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/CCO.0000000000000053","volume":"26","author":"DC Christoph","year":"2014","unstructured":"Christoph, D.C. & Eberhardt, W.E. Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvements. Curr. Opin. Oncol. 26, 171\u2013181 (2014).","journal-title":"Curr. Opin. Oncol."},{"key":"BFng3520_CR6","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.athoracsur.2004.05.007","volume":"78","author":"R Bueno","year":"2004","unstructured":"Bueno, R. et al. Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann. Thorac. Surg. 78, 1774\u20131776 (2004).","journal-title":"Ann. Thorac. Surg."},{"key":"BFng3520_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/SLA.0000000000000903","volume":"260","author":"DJ Sugarbaker","year":"2014","unstructured":"Sugarbaker, D.J., Richards, W.G. & Bueno, R. Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients. Ann. Surg. 260, 577\u2013580, discussion 580\u2013582 (2014).","journal-title":"Ann. Surg."},{"key":"BFng3520_CR8","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1016\/j.jtcvs.2014.10.128","volume":"149","author":"EH Baldini","year":"2015","unstructured":"Baldini, E.H. et al. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 149, 1374\u20131381 (2015).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"BFng3520_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ctrv.2014.10.007","volume":"41","author":"J Remon","year":"2015","unstructured":"Remon, J., Reguart, N., Corral, J. & Lianes, P. Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies. Cancer Treat. Rev. 41, 27\u201334 (2015).","journal-title":"Cancer Treat. Rev."},{"key":"BFng3520_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1471-2350-10-149","volume":"10","author":"L Dong","year":"2009","unstructured":"Dong, L. et al. Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing. BMC Med. Genet. 10, 149 (2009).","journal-title":"BMC Med. Genet."},{"key":"BFng3520_CR11","doi-asserted-by":"publisher","first-page":"e10612","DOI":"10.1371\/journal.pone.0010612","volume":"5","author":"R Bueno","year":"2010","unstructured":"Bueno, R. et al. Second generation sequencing of the mesothelioma tumor genome. PLoS One 5, e10612 (2010).","journal-title":"PLoS One"},{"key":"BFng3520_CR12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.855","volume":"43","author":"M Bott","year":"2011","unstructured":"Bott, M. et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat. Genet. 43, 668\u2013672 (2011).","journal-title":"Nat. Genet."},{"key":"BFng3520_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","volume":"75","author":"G Guo","year":"2015","unstructured":"Guo, G. et al. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma. Cancer Res. 75, 264\u2013269 (2015).","journal-title":"Cancer Res."},{"key":"BFng3520_CR14","doi-asserted-by":"publisher","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","volume":"92","author":"AB Bianchi","year":"1995","unstructured":"Bianchi, A.B. et al. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc. Natl. Acad. Sci. USA 92, 10854\u201310858 (1995).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng3520_CR15","first-page":"5547","volume":"54","author":"JQ Cheng","year":"1994","unstructured":"Cheng, J.Q. et al. p16 alterations and deletion mapping of 9p21\u2013p22 in malignant mesothelioma. Cancer Res. 54, 5547\u20135551 (1994).","journal-title":"Cancer Res."},{"key":"BFng3520_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.celrep.2012.12.008","volume":"3","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L.B., Nik-Zainal, S., Wedge, D.C., Campbell, P.J. & Stratton, M.R. Deciphering signatures of mutational processes operative in human cancer. Cell Reports 3, 246\u2013259 (2013).","journal-title":"Cell Reports"},{"key":"BFng3520_CR17","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa, J.R. et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat. Genet. 43, 1022\u20131025 (2011).","journal-title":"Nat. Genet."},{"key":"BFng3520_CR18","unstructured":"Travis, W.D., Brambilla, E., M\u00fcller-Hermelink, H.K. & Harris, C.C. WHO Classification of Tumors of the Lung, Pleura, Thymus and Heart (IARC Press, 2004)."},{"key":"BFng3520_CR19","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/jclinpath-2012-201303","volume":"66","author":"DW Henderson","year":"2013","unstructured":"Henderson, D.W., Reid, G., Kao, S.C., van Zandwijk, N. & Klebe, S. Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers. J. Clin. Pathol. 66, 847\u2013853 (2013).","journal-title":"J. Clin. Pathol."},{"key":"BFng3520_CR20","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/jnci\/95.8.598","volume":"95","author":"GJ Gordon","year":"2003","unstructured":"Gordon, G.J. et al. Using gene expression ratios to predict outcome among patients with mesothelioma. J. Natl. Cancer Inst. 95, 598\u2013605 (2003).","journal-title":"J. Natl. Cancer Inst."},{"key":"BFng3520_CR21","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0002-9440(10)62492-3","volume":"166","author":"GJ Gordon","year":"2005","unstructured":"Gordon, G.J. et al. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am. J. Pathol. 166, 1827\u20131840 (2005).","journal-title":"Am. J. Pathol."},{"key":"BFng3520_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1158\/1078-0432.CCR-0607-3","volume":"10","author":"HI Pass","year":"2004","unstructured":"Pass, H.I. et al. Gene expression profiles predict survival and progression of pleural mesothelioma. Clin. Cancer Res. 10, 849\u2013859 (2004).","journal-title":"Clin. Cancer Res."},{"key":"BFng3520_CR23","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.1158\/0008-5472.CAN-05-3907","volume":"66","author":"F L\u00f3pez-R\u00edos","year":"2006","unstructured":"L\u00f3pez-R\u00edos, F. et al. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res. 66, 2970\u20132979 (2006).","journal-title":"Cancer Res."},{"key":"BFng3520_CR24","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-13-2429","volume":"20","author":"A de Reyni\u00e8s","year":"2014","unstructured":"de Reyni\u00e8s, A. et al. Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition. Clin. Cancer Res. 20, 1323\u20131334 (2014).","journal-title":"Clin. Cancer Res."},{"key":"BFng3520_CR25","doi-asserted-by":"publisher","first-page":"e25391","DOI":"10.1371\/journal.pone.0025391","volume":"6","author":"M Kanamori-Katayama","year":"2011","unstructured":"Kanamori-Katayama, M. et al. LRRN4 and UPK3B are markers of primary mesothelial cells. PLoS One 6, e25391 (2011).","journal-title":"PLoS One"},{"key":"BFng3520_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille, S., Xu, J. & Derynck, R. Molecular mechanisms of epithelial-mesenchymal transition. Nat. Rev. Mol. Cell Biol. 15, 178\u2013196 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFng3520_CR27","doi-asserted-by":"publisher","first-page":"30000","DOI":"10.1074\/jbc.C113.502310","volume":"288","author":"HJ Moon","year":"2013","unstructured":"Moon, H.J. et al. MCF-7 cells expressing nuclear associated lysyl oxidase\u2013like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro. J. Biol. Chem. 288, 30000\u201330008 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFng3520_CR28","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ng.3146","volume":"47","author":"S Durinck","year":"2015","unstructured":"Durinck, S. et al. Spectrum of diverse genomic alterations define non\u2013clear cell renal carcinoma subtypes. Nat. Genet. 47, 13\u201321 (2015).","journal-title":"Nat. Genet."},{"key":"BFng3520_CR29","doi-asserted-by":"publisher","first-page":"D652","DOI":"10.1093\/nar\/gkp995","volume":"38","author":"SA Forbes","year":"2010","unstructured":"Forbes, S.A. et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res. 38, D652\u2013D657 (2010).","journal-title":"Nucleic Acids Res."},{"key":"BFng3520_CR30","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676\u2013690 (2014)."},{"key":"BFng3520_CR31","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059\u20132074 (2013).","DOI":"10.1056\/NEJMoa1301689"},{"key":"BFng3520_CR32","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979\u2013993 (2012).","journal-title":"Cell"},{"key":"BFng3520_CR33","doi-asserted-by":"crossref","first-page":"16848","DOI":"10.18632\/oncotarget.4253","volume":"6","author":"S Benedetti","year":"2015","unstructured":"Benedetti, S., Nuvoli, B., Catalani, S. & Galati, R. Reactive oxygen species a double-edged sword for mesothelioma. Oncotarget 6, 16848\u201316865 (2015).","journal-title":"Oncotarget"},{"key":"BFng3520_CR34","first-page":"259","volume":"301","author":"GP Pfeifer","year":"2006","unstructured":"Pfeifer, G.P. Mutagenesis at methylated CpG sequences. Curr. Top. Microbiol. Immunol. 301, 259\u2013281 (2006).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"BFng3520_CR35","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1101\/gr.212802","volume":"12","author":"PC Ng","year":"2002","unstructured":"Ng, P.C. & Henikoff, S. Accounting for human polymorphisms predicted to affect protein function. Genome Res. 12, 436\u2013446 (2002).","journal-title":"Genome Res."},{"key":"BFng3520_CR36","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1093\/nar\/gkf493","volume":"30","author":"V Ramensky","year":"2002","unstructured":"Ramensky, V., Bork, P. & Sunyaev, S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 30, 3894\u20133900 (2002).","journal-title":"Nucleic Acids Res."},{"key":"BFng3520_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.ajhg.2011.03.004","volume":"88","author":"A Gonz\u00e1lez-P\u00e9rez","year":"2011","unstructured":"Gonz\u00e1lez-P\u00e9rez, A. & L\u00f3pez-Bigas, N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am. J. Hum. Genet. 88, 440\u2013449 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng3520_CR38","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nature09208","volume":"466","author":"Z Kan","year":"2010","unstructured":"Kan, Z. et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869\u2013873 (2010).","journal-title":"Nature"},{"key":"BFng3520_CR39","doi-asserted-by":"publisher","first-page":"8090","DOI":"10.1158\/0008-5472.CAN-05-2312","volume":"65","author":"DA Altomare","year":"2005","unstructured":"Altomare, D.A. et al. A mouse model recapitulating molecular features of human mesothelioma. Cancer Res. 65, 8090\u20138095 (2005).","journal-title":"Cancer Res."},{"key":"BFng3520_CR40","doi-asserted-by":"publisher","first-page":"22306","DOI":"10.1074\/jbc.M114.567032","volume":"289","author":"S Shukla","year":"2014","unstructured":"Shukla, S. et al. Methylation silencing of ULK2, an autophagy gene, is essential for astrocyte transformation and tumor growth. J. Biol. Chem. 289, 22306\u201322318 (2014).","journal-title":"J. Biol. Chem."},{"key":"BFng3520_CR41","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1007\/s00018-006-6274-5","volume":"63","author":"C Qian","year":"2006","unstructured":"Qian, C. & Zhou, M.M. SET domain protein lysine methyltransferases: structure, specificity and catalysis. Cell. Mol. Life Sci. 63, 2755\u20132763 (2006).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFng3520_CR42","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"MS Lawrence","year":"2014","unstructured":"Lawrence, M.S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495\u2013501 (2014).","journal-title":"Nature"},{"key":"BFng3520_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature11213","volume":"488","author":"G Robinson","year":"2012","unstructured":"Robinson, G. et al. Novel mutations target distinct subgroups of medulloblastoma. Nature 488, 43\u201348 (2012).","journal-title":"Nature"},{"key":"BFng3520_CR44","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature11329","volume":"488","author":"TJ Pugh","year":"2012","unstructured":"Pugh, T.J. et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106\u2013110 (2012).","journal-title":"Nature"},{"key":"BFng3520_CR45","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature11284","volume":"488","author":"DT Jones","year":"2012","unstructured":"Jones, D.T. et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 488, 100\u2013105 (2012).","journal-title":"Nature"},{"key":"BFng3520_CR46","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ng.3358","volume":"47","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. Exome sequencing identifies somatic mutations of DDX3X in natural killer\/T-cell lymphoma. Nat. Genet. 47, 1061\u20131066 (2015).","journal-title":"Nat. Genet."},{"key":"BFng3520_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jmb.2014.08.004","volume":"427","author":"F Van Petegem","year":"2015","unstructured":"Van Petegem, F. Ryanodine receptors: allosteric ion channel giants. J. Mol. Biol. 427, 31\u201353 (2015).","journal-title":"J. Mol. Biol."},{"key":"BFng3520_CR48","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1111\/jcmm.12317","volume":"18","author":"Z Liu","year":"2014","unstructured":"Liu, Z. et al. Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of c-Myc thereby suppressing cell growth in non\u2013small cell lung cancers. J. Cell. Mol. Med. 18, 1667\u20131679 (2014).","journal-title":"J. Cell. Mol. Med."},{"key":"BFng3520_CR49","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark, V.E. et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339, 1077\u20131080 (2013).","journal-title":"Science"},{"key":"BFng3520_CR50","doi-asserted-by":"publisher","first-page":"R96","DOI":"10.1186\/gb-2011-12-9-r96","volume":"12","author":"W Yu","year":"2011","unstructured":"Yu, W. et al. First somatic mutation of E2F1 in a critical DNA binding residue discovered in well-differentiated papillary mesothelioma of the peritoneum. Genome Biol. 12, R96 (2011).","journal-title":"Genome Biol."},{"key":"BFng3520_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.5858\/arpa.2011-0215-RA","volume":"136","author":"D Jean","year":"2012","unstructured":"Jean, D., Daubriac, J., Le Pimpec-Barthes, F., Galateau-Salle, F. & Jaurand, M.C. Molecular changes in mesothelioma with an impact on prognosis and treatment. Arch. Pathol. Lab. Med. 136, 277\u2013293 (2012).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"BFng3520_CR52","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.cell.2005.12.042","volume":"124","author":"S Wolff","year":"2006","unstructured":"Wolff, S. et al. SMK-1, an essential regulator of DAF-16\u2013mediated longevity. Cell 124, 1039\u20131053 (2006).","journal-title":"Cell"},{"key":"BFng3520_CR53","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1158\/2159-8290.CD-11-0028","volume":"1","author":"S Durinck","year":"2011","unstructured":"Durinck, S. et al. Temporal dissection of tumorigenesis in primary cancers. Cancer Discov. 1, 137\u2013143 (2011).","journal-title":"Cancer Discov."},{"key":"BFng3520_CR54","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nbt.3080","volume":"33","author":"C Klijn","year":"2015","unstructured":"Klijn, C. et al. A comprehensive transcriptional portrait of human cancer cell lines. Nat. Biotechnol. 33, 306\u2013312 (2015).","journal-title":"Nat. Biotechnol."},{"key":"BFng3520_CR55","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1038\/onc.2013.533","volume":"33","author":"S Oltean","year":"2014","unstructured":"Oltean, S. & Bates, D.O. Hallmarks of alternative splicing in cancer. Oncogene 33, 5311\u20135318 (2014).","journal-title":"Oncogene"},{"key":"BFng3520_CR56","unstructured":"GTEx Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648\u2013660 (2015)."},{"key":"BFng3520_CR57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/j.1460-2075.1989.tb03358.x","volume":"8","author":"WM Franz","year":"1989","unstructured":"Franz, W.M., Berger, P. & Wang, J.Y. Deletion of an N-terminal regulatory domain of the c-Abl tyrosine kinase activates its oncogenic potential. EMBO J. 8, 137\u2013147 (1989).","journal-title":"EMBO J."},{"key":"BFng3520_CR58","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/wrna.1222","volume":"5","author":"K Yoshida","year":"2014","unstructured":"Yoshida, K. & Ogawa, S. Splicing factor mutations and cancer. Wiley Interdiscip. Rev. RNA 5, 445\u2013459 (2014).","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"BFng3520_CR59","doi-asserted-by":"publisher","first-page":"e1004105","DOI":"10.1371\/journal.pcbi.1004105","volume":"11","author":"C DeBoever","year":"2015","unstructured":"DeBoever, C. et al. Transcriptome sequencing reveals potential mechanism of cryptic 3\u2032 splice site selection in SF3B1-mutated cancers. PLoS Comput. Biol. 11, e1004105 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"BFng3520_CR60","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","volume":"3","author":"SJ Furney","year":"2013","unstructured":"Furney, S.J. et al. SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov. 3, 1122\u20131129 (2013).","journal-title":"Cancer Discov."},{"key":"BFng3520_CR61","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1158\/0008-5472.CAN-14-1596","volume":"75","author":"LU Rodrigues","year":"2015","unstructured":"Rodrigues, L.U. et al. Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer. Cancer Res. 75, 1021\u20131034 (2015).","journal-title":"Cancer Res."},{"key":"BFng3520_CR62","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd3823","volume":"11","author":"S Bonnal","year":"2012","unstructured":"Bonnal, S., Vigevani, L. & Valc\u00e1rcel, J. The spliceosome as a target of novel antitumour drugs. Nat. Rev. Drug Discov. 11, 847\u2013859 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"BFng3520_CR63","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1182\/blood-2012-09-399725","volume":"121","author":"M Cazzola","year":"2013","unstructured":"Cazzola, M., Rossi, M. & Malcovati, L. Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms. Blood 121, 260\u2013269 (2013).","journal-title":"Blood"},{"key":"BFng3520_CR64","doi-asserted-by":"publisher","first-page":"e1009285","DOI":"10.1080\/2162402X.2015.1009285","volume":"4","author":"H Ujiie","year":"2015","unstructured":"Ujiie, H. et al. The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: a comprehensive analysis reveals prognostic immune markers. OncoImmunology 4, e1009285 (2015).","journal-title":"OncoImmunology"},{"key":"BFng3520_CR65","doi-asserted-by":"publisher","first-page":"e106742","DOI":"10.1371\/journal.pone.0106742","volume":"9","author":"R Cornelissen","year":"2014","unstructured":"Cornelissen, R. et al. Ratio of intratumoral macrophage phenotypes is a prognostic factor in epithelioid malignant pleural mesothelioma. PLoS One 9, e106742 (2014).","journal-title":"PLoS One"},{"key":"BFng3520_CR66","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1101\/gr.116335.110","volume":"21","author":"JM Toung","year":"2011","unstructured":"Toung, J.M., Morley, M., Li, M. & Cheung, V.G. RNA-sequence analysis of human B-cells. Genome Res. 21, 991\u2013998 (2011).","journal-title":"Genome Res."},{"key":"BFng3520_CR67","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2559.2005.02331.x","volume":"48","author":"JE King","year":"2006","unstructured":"King, J.E., Thatcher, N., Pickering, C.A. & Hasleton, P.S. Sensitivity and specificity of immunohistochemical markers used in the diagnosis of epithelioid mesothelioma: a detailed systematic analysis using published data. Histopathology 48, 223\u2013232 (2006).","journal-title":"Histopathology"},{"key":"BFng3520_CR68","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.anndiagpath.2015.03.007","volume":"19","author":"S Chaouche-Mazouni","year":"2015","unstructured":"Chaouche-Mazouni, S. et al. Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma. Ann. Diagn. Pathol. 19, 193\u2013197 (2015).","journal-title":"Ann. Diagn. Pathol."},{"key":"BFng3520_CR69","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/JTO.0000000000000493","volume":"10","author":"A Miyanaga","year":"2015","unstructured":"Miyanaga, A. et al. Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing. J. Thorac. Oncol. 10, 844\u2013851 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"BFng3520_CR70","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/10520290701488121","volume":"82","author":"WG Richards","year":"2007","unstructured":"Richards, W.G. et al. A microaliquoting technique for precise histological annotation and optimization of cell content in frozen tissue specimens. Biotech. Histochem. 82, 189\u2013197 (2007).","journal-title":"Biotech. Histochem."},{"key":"BFng3520_CR71","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1093\/bioinformatics\/btp450","volume":"25","author":"M Morgan","year":"2009","unstructured":"Morgan, M. et al. ShortRead: a Bioconductor package for input, quality assessment and exploration of high-throughput sequence data. Bioinformatics 25, 2607\u20132608 (2009).","journal-title":"Bioinformatics"},{"key":"BFng3520_CR72","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754\u20131760 (2009).","journal-title":"Bioinformatics"},{"key":"BFng3520_CR73","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo, M.A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491\u2013498 (2011).","journal-title":"Nat. Genet."},{"key":"BFng3520_CR74","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1093\/bioinformatics\/bts271","volume":"28","author":"CT Saunders","year":"2012","unstructured":"Saunders, C.T. et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28, 1811\u20131817 (2012).","journal-title":"Bioinformatics"},{"key":"BFng3520_CR75","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry, S.T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308\u2013311 (2001).","journal-title":"Nucleic Acids Res."},{"key":"BFng3520_CR76","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature11690","volume":"493","author":"W Fu","year":"2013","unstructured":"Fu, W. et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 493, 216\u2013220 (2013).","journal-title":"Nature"},{"key":"BFng3520_CR77","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"BFng3520_CR78","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"BFng3520_CR79","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/ng.2405","volume":"44","author":"CM Rudin","year":"2012","unstructured":"Rudin, C.M. et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat. Genet. 44, 1111\u20131116 (2012).","journal-title":"Nat. Genet."},{"key":"BFng3520_CR80","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/ng.2396","volume":"44","author":"M Peifer","year":"2012","unstructured":"Peifer, M. et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat. Genet. 44, 1104\u20131110 (2012).","journal-title":"Nat. Genet."},{"key":"BFng3520_CR81","doi-asserted-by":"publisher","first-page":"4164","DOI":"10.1073\/pnas.0308531101","volume":"101","author":"JP Brunet","year":"2004","unstructured":"Brunet, J.P., Tamayo, P., Golub, T.R. & Mesirov, J.P. Metagenes and molecular pattern discovery using matrix factorization. Proc. Natl. Acad. Sci. USA 101, 4164\u20134169 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng3520_CR82","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1101\/gr.134635.111","volume":"22","author":"ND Dees","year":"2012","unstructured":"Dees, N.D. et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 22, 1589\u20131598 (2012).","journal-title":"Genome Res."},{"key":"BFng3520_CR83","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence, M.S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214\u2013218 (2013).","journal-title":"Nature"},{"key":"BFng3520_CR84","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/bioinformatics\/btq057","volume":"26","author":"TD Wu","year":"2010","unstructured":"Wu, T.D. & Nacu, S. Fast and SNP-tolerant detection of complex variants and splicing in short reads. Bioinformatics 26, 873\u2013881 (2010).","journal-title":"Bioinformatics"},{"key":"BFng3520_CR85","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M.D., McCarthy, D.J. & Smyth, G.K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140 (2010).","journal-title":"Bioinformatics"},{"key":"BFng3520_CR86","doi-asserted-by":"publisher","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","volume":"11","author":"S Anders","year":"2010","unstructured":"Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol. 11, R106 (2010).","journal-title":"Genome Biol."},{"key":"BFng3520_CR87","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546\u20131558 (2013).","journal-title":"Science"},{"key":"BFng3520_CR88","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M.E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"BFng3520_CR89","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1093\/bioinformatics\/bti310","volume":"21","author":"TD Wu","year":"2005","unstructured":"Wu, T.D. & Watanabe, C.K. GMAP: a genomic mapping and alignment program for mRNA and EST sequences. Bioinformatics 21, 1859\u20131875 (2005).","journal-title":"Bioinformatics"},{"key":"BFng3520_CR90","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1093\/biostatistics\/kxp045","volume":"11","author":"CD Greenman","year":"2010","unstructured":"Greenman, C.D. et al. PICNIC: an algorithm to predict absolute allelic copy number variation with microarray cancer data. Biostatistics 11, 164\u2013175 (2010).","journal-title":"Biostatistics"},{"key":"BFng3520_CR91","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/biostatistics\/kxm013","volume":"9","author":"R Tibshirani","year":"2008","unstructured":"Tibshirani, R. & Wang, P. Spatial smoothing and hot spot detection for CGH data using the fused lasso. Biostatistics 9, 18\u201329 (2008).","journal-title":"Biostatistics"},{"key":"BFng3520_CR92","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel, C.H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).","journal-title":"Genome Biol."},{"key":"BFng3520_CR93","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/gm403","volume":"4","author":"S Boegel","year":"2012","unstructured":"Boegel, S. et al. HLA typing from RNA-Seq sequence reads. Genome Med. 4, 102 (2012).","journal-title":"Genome Med."},{"key":"BFng3520_CR94","doi-asserted-by":"publisher","first-page":"D405","DOI":"10.1093\/nar\/gku938","volume":"43","author":"R Vita","year":"2015","unstructured":"Vita, R. et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 43, D405\u2013D412 (2015).","journal-title":"Nucleic Acids Res."},{"key":"BFng3520_CR95","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ccell.2014.10.018","volume":"26","author":"RJ Johnston","year":"2014","unstructured":"Johnston, R.J. et al. The immunoreceptor TIGIT regulates antitumor and antiviral CD8+ T cell effector function. Cancer Cell 26, 923\u2013937 (2014).","journal-title":"Cancer Cell"},{"key":"BFng3520_CR96","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M.I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"BFng3520_CR97","doi-asserted-by":"publisher","first-page":"D691","DOI":"10.1093\/nar\/gkq1018","volume":"39","author":"D Croft","year":"2011","unstructured":"Croft, D. et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 39, D691\u2013D697 (2011).","journal-title":"Nucleic Acids Res."},{"key":"BFng3520_CR98","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.3390\/cancers4041180","volume":"4","author":"M Milacic","year":"2012","unstructured":"Milacic, M. et al. Annotating cancer variants and anti-cancer therapeutics in reactome. Cancers (Basel) 4, 1180\u20131211 (2012).","journal-title":"Cancers (Basel)"},{"key":"BFng3520_CR99","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng3520_CR100","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1101\/gr.133744.111","volume":"22","author":"S Anders","year":"2012","unstructured":"Anders, S., Reyes, A. & Huber, W. Detecting differential usage of exons from RNA-seq data. Genome Res. 22, 2008\u20132017 (2012).","journal-title":"Genome Res."}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng.3520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.3520","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng.3520.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:12:19Z","timestamp":1684429939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng.3520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,29]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["BFng3520"],"URL":"https:\/\/doi.org\/10.1038\/ng.3520","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,29]]},"assertion":[{"value":"10 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.W.S., L.D.G., S.D., Z.M., F.G., T.T.N., B.S.J., J.A.H., A.C., R.G., J.G., K.T., C.H., Y.-J.C., J.S., S.C., N.Z., T.D.W., F.J.d.S. and S.S. are employees of Genentech Inc. or MedGenome Labs Pvt. Ltd. E.W.S., S.D., Z.M., F.G., B.J.S., J.A.H., J.G., K.T., C.H., Y.-J.C., J.S., S.C., N.Z., T.D.W., F.J.d.S. and S.S. hold shares in Roche. A.C. and R.G. hold stock options in MedGenome.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}